|

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

RECRUITINGN/ASponsored by Seoul National University Hospital
Actively Recruiting
PhaseN/A
SponsorSeoul National University Hospital
Started2023-11-07
Est. completion2025-09-30
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05996159

Summary

This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients undergoing PVI for PAF

Exclusion Criteria:

* Aged less than 19 years
* Patients with persistent AF
* Patients with previous ablation or surgery for AF
* Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
* Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
* Patients with contraindication(s) for using oral anticoagulants
* Patients with LA anteroposterior diameter of more than 55 mm
* Patients with left ventricular ejection fraction less than 35%
* Pregnants or those who plan to become pregnant during the study
* Life expectancy less than a year

Conditions2

Heart DiseaseParoxysmal Atrial Fibrillation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.